首页> 外文期刊>Molecular and Cellular Biology >A dominant negative mutation of the alpha retinoic acid receptor gene in a retinoic acid-nonresponsive embryonal carcinoma cell.
【24h】

A dominant negative mutation of the alpha retinoic acid receptor gene in a retinoic acid-nonresponsive embryonal carcinoma cell.

机译:视黄酸无反应的胚胎癌细胞中α视黄酸受体基因的显性负突变。

获取原文
           

摘要

Pluripotential embryonal carcinoma cells such as those of the P19 line differentiate when exposed to retinoic acid (RA). The RAC65 cell line is a mutant clone of P19 cells selected to be RA nonresponsive. RAC65 cells carry a rearrangement affecting one of the genes encoding a nuclear retinoic acid receptor (RAR alpha). The mutant gene encodes a protein, RAR alpha', that has lost its 70 C-terminal amino acids, thus truncating the RA-binding domain. The RAR alpha' was found to be a dominant repressor of transcription from an RA-responsive target gene; however, expression of RAR alpha' was insufficient to confer RA nonresponsiveness, suggesting that RAC65 cells carry an additional mutation(s) affecting RA-induced genes.
机译:当暴露于视黄酸(RA)时,多能胚胎癌细胞(例如P19系的那些)会分化。 RAC65细胞系是被选为RA无反应的P19细胞的突变克隆。 RAC65细胞进行重排,影响编码核视黄酸受体(RAR alpha)的基因之一。突变基因编码一种蛋白质RAR alpha',该蛋白质失去了其70个C端氨基酸,从而截断了RA结合域。发现RAR alpha'是RA反应性靶基因转录的主要阻遏物。然而,RAR alpha'的表达不足以赋予RA无反应性,表明RAC65细胞带有影响RA诱导基因的其他突变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号